Livagen is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Livagen (Lys-Glu-Asp-Ala tetrapeptide) is researched primarily for chromatin remodeling, protein synthesis regulation, antioxidant enhancement, liver health support, immune function. A true chromatin-remodeling peptide that works through enzyme inhibition rather than receptor activation — mechanistically distinct from nearly every other peptide on the market. It belongs to the Peptide bioregulator category of compounds.
What Is Livagen?
Livagen (Lys-Glu-Asp-Ala tetrapeptide) is a Peptide bioregulator. Synthetic Russian-developed peptide bioregulator for epigenetic regulation and chromatin remodeling.
A true chromatin-remodeling peptide that works through enzyme inhibition rather than receptor activation — mechanistically distinct from nearly every other peptide on the market. It has attracted significant research interest for its potential effects on chromatin remodeling, protein synthesis regulation, antioxidant enhancement, liver health support, immune function.
How Does Livagen Produce These Benefits?
Inhibits enkephalin-degrading enzymes (IC50: 20 μM) and promotes chromatin decondensation to activate silenced genes. Modulates the endogenous opioid system by preventing enkephalin breakdown rather than directly binding opioid receptors, allowing endogenous opioids to exert their effects longer.
This multi-pathway activity is why Livagen shows potential across several different applications rather than being limited to a single use case.
Can Livagen Help With Chromatin Remodeling?
Research suggests Livagen may support chromatin remodeling through its peptide bioregulator activity. Animal studies document enzyme inhibition and metabolic effects. Multiple Russian peer-reviewed studies available. No human clinical trials conducted.
Protocols targeting chromatin remodeling typically use 200 mcg daily administered once daily for 10-14 day cycles with 6-12 week breaks.
Can Livagen Help With Protein Synthesis Regulation?
Research suggests Livagen may support protein synthesis regulation through its peptide bioregulator activity. Animal studies document enzyme inhibition and metabolic effects. Multiple Russian peer-reviewed studies available. No human clinical trials conducted.
Protocols targeting protein synthesis regulation typically use 200 mcg daily administered once daily for 10-14 day cycles with 6-12 week breaks.
Can Livagen Help With Antioxidant Enhancement?
Research suggests Livagen may support antioxidant enhancement through its peptide bioregulator activity. Animal studies document enzyme inhibition and metabolic effects. Multiple Russian peer-reviewed studies available. No human clinical trials conducted.
Protocols targeting antioxidant enhancement typically use 200 mcg daily administered once daily for 10-14 day cycles with 6-12 week breaks.
Can Livagen Help With Liver Health Support?
Research suggests Livagen may support liver health support through its peptide bioregulator activity. Animal studies document enzyme inhibition and metabolic effects. Multiple Russian peer-reviewed studies available. No human clinical trials conducted.
Protocols targeting liver health support typically use 200 mcg daily administered once daily for 10-14 day cycles with 6-12 week breaks.
Can Livagen Help With Immune Function?
Research suggests Livagen may support immune function through its peptide bioregulator activity. Animal studies document enzyme inhibition and metabolic effects. Multiple Russian peer-reviewed studies available. No human clinical trials conducted.
Protocols targeting immune function typically use 200 mcg daily administered once daily for 10-14 day cycles with 6-12 week breaks.
Can Stacking Enhance Livagen Benefits?
Pairs with Epithalon (another Russian bioregulator) for synergistic anti-aging and immune effects through complementary epigenetic pathways.
See our Livagen stacking guide for detailed combination protocols.
What Is the Bottom Line on Livagen Benefits?
Livagen is researched for chromatin remodeling, protein synthesis regulation, antioxidant enhancement, liver health support, immune function. The evidence base includes: Animal studies document enzyme inhibition and metabolic effects. Multiple Russian peer-reviewed studies available. No human clinical trials conducted.
Livagen is not fda-approved. research chemical only. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
Livagen : Benefits, Dosage, Side Effects & Research
Related Reading
- Livagen Dosage Guide
- Livagen Side Effects
- Livagen Stacking Guide
- Livagen Cycle Guide
- Livagen Research
- Epithalon Complete Guide
Calculate Your Livagen Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Livagen.
Open Calculator →Research-Grade Sourcing
If you're going to research Livagen, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Livagen?
Livagen (Lys-Glu-Asp-Ala tetrapeptide) is a Peptide bioregulator. Synthetic Russian-developed peptide bioregulator for epigenetic regulation and chromatin remodeling. It is researched for chromatin remodeling, protein synthesis regulation, antioxidant enhancement, liver health support, immune function.
What is the recommended Livagen dosage?
Common dosages: 200 mcg daily administered once daily via subcutaneous injection. Cycle length: 10-14 day cycles with 6-12 week breaks. Half-life: unknown; resistant to intestinal peptidase degradation. Use our peptide calculator for exact reconstitution math.
What are the side effects of Livagen?
Limited human data. Well-tolerated in research models. No serious side effects documented.
Is Livagen safe?
Livagen has shown a favorable safety profile in research. Not FDA-approved. Research chemical only. All research should follow appropriate safety protocols.